Fred Alger Management’s Moderna MRNA Stock Holding History

Fred Alger Management’s Portfolio MRNA Stock Details MRNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.5M	Buy	+21,435	New	+$1.11M	0.01%	337
2023 Q3	–	Sell	-190	Closed	-$23.1K	–	509
2023 Q2	$23.1K	Hold	190	–	–	﹤0.01%	487
2023 Q1	$29.2K	Sell	190 -204,363	-100%	-$33.7M	﹤0.01%	478
2022 Q4	$36.7M	Buy	+204,553	New	+$33.4M	0.2%	137
2021 Q4	–	Sell	-32,139	Closed	-$12.4M	–	540
2021 Q3	$12.4M	Sell	32,139 -66,680	-67%	-$24.6M	0.03%	225
2021 Q2	$23.2M	Buy	+98,819	New	+$17.7M	0.05%	202
2020 Q4	–	Sell	-269,077	Closed	-$19M	–	490
2020 Q3	$19M	Sell	269,077 -26,201	-9%	-$1.83M	0.06%	172
2020 Q2	$19M	Buy	295,278 +66,307	+29%	+$3.63M	0.06%	164
2020 Q1	$6.86M	Buy	+228,971	New	+$5.27M	0.03%	195
2019 Q4	–	Sell	-10,000	Closed	-$159K	–	506
2019 Q3	$159K	Buy	+10,000	New	+$148K	﹤0.01%	403
2019 Q2	–	Sell	-21,000	Closed	-$427K	–	541
2019 Q1	$427K	Buy	+21,000	New	+$390K	﹤0.01%	376

Other funds holding MRNA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Fred Alger Management's MRNA Position: Q2 2026 in Review

Fred Alger Management opened a new position in Moderna (MRNA) in Q2 2026: 21,435 shares worth $1.5M. The stake represents 0.01% of the portfolio and ranks #337 among its holdings. This is a return to the name: Fred Alger Management previously reported a position in MRNA as recently as Q2 2023.

Fred Alger Management first reported a position in MRNA in Q1 2019 and has held it in 11 quarters since. The position peaked at $36.7M in Q4 2022. 782 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

Fred Alger Management held 21,435 shares of Moderna worth $1.5M as of Q2 2026.
Moderna was a new Fred Alger Management position in Q2 2026.
Moderna made up 0.01% of Fred Alger Management's portfolio in Q2 2026, its #337 holding.
Fred Alger Management first reported a position in Moderna in Q1 2019 and has held it in 11 quarters since.
Fred Alger Management's Moderna position peaked at $36.7M in Q4 2022.
782 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Fred Alger Management's 13F filing for Q2 2026, filed 14 Aug 2026.